Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;15(2):289-300.
doi: 10.1016/j.jsmc.2020.02.014.

Drugs Used in Parasomnia

Paola Proserpio  1 , Michele Terzaghi  2 , Raffaele Manni  2 , Lino Nobili  3
Affiliations
Review

Drugs Used in Parasomnia

Paola Proserpio et al. Sleep Med Clin. 2020 Jun.

Abstract

Patient education and behavioral management represent the first treatment approaches to the patient with parasomnia, especially in case of disorders of arousal (DOA). A pharmacologic treatment of DOA may be useful when episodes are frequent and persist despite resolution of predisposing factors, are associated with a high risk of injury, or cause significant impairment, such as excessive sleepiness. Approved drugs for DOA are still lacking. The most commonly used medications are benzodiazepines and antidepressants. The pharmacologic treatment of rapid eye movement sleep behavior disorder is symptomatic, and the most commonly used drugs are clonazepam and melatonin.

Keywords: Antidepressant drugs; Benzodiazepines; Clonazepam; Disorders of arousal; Melatonin; REM behavior disorder; Sleep enuresis; Sleep-related eating disorder.

PubMed Disclaimer

Similar articles

  • Drugs Used in Parasomnia.
    Proserpio P, Terzaghi M, Manni R, Nobili L. Proserpio P, et al. Sleep Med Clin. 2018 Jun;13(2):191-202. doi: 10.1016/j.jsmc.2018.02.003. Epub 2018 Mar 17. Sleep Med Clin. 2018. PMID: 29759270 Review.
  • Drugs Used in Parasomnia.
    Proserpio P, Terzaghi M, Manni R, Nobili L. Proserpio P, et al. Sleep Med Clin. 2022 Sep;17(3):367-378. doi: 10.1016/j.jsmc.2022.06.004. Sleep Med Clin. 2022. PMID: 36150800 Review.
  • NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients.
    Drakatos P, Marples L, Muza R, Higgins S, Gildeh N, Macavei R, Dongol EM, Nesbitt A, Rosenzweig I, Lyons E, d'Ancona G, Steier J, Williams AJ, Kent BD, Leschziner G. Drakatos P, et al. Sleep Med. 2019 Jan;53:181-188. doi: 10.1016/j.sleep.2018.03.021. Epub 2018 Apr 10. Sleep Med. 2019. PMID: 29753639 Free PMC article.
  • Therapeutic Symptomatic Strategies in the Parasomnias.
    Manni R, Toscano G, Terzaghi M. Manni R, et al. Curr Treat Options Neurol. 2018 Jun 5;20(7):26. doi: 10.1007/s11940-018-0508-3. Curr Treat Options Neurol. 2018. PMID: 29869076 Review.
  • Parasomnias: an updated review.
    Howell MJ. Howell MJ. Neurotherapeutics. 2012 Oct;9(4):753-75. doi: 10.1007/s13311-012-0143-8. Neurotherapeutics. 2012. PMID: 22965264 Free PMC article. Review.
See all similar articles

Cited by

MeSH terms

LinkOut - more resources